The Massachusetts-based startup aims to advance testing for parasitic and viral diseases including Chagas, Zika, and Lyme, and tapeworm and liver fluke infections.
Ultra-Cheap, Sensitive DNA Nanoswitch Tech Developed for SARS-CoV-2 Detection
The method uses standard lab equipment and the nanoswitches can be easily reconfigured and made in large batches at a cost of about $0.01 per reaction.
Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
Kephera Diagnostics Wins $2M SBIR Grant From NIAID to Develop Zika Virus Antibody Test
The test is aimed at detecting Zika antibodies in a highly specific way that avoids cross-reactivity with the dengue virus, according to the firm.
Chembio Diagnostics Receives FDA Clearance for Zika Virus Antibody Detection System
The system detects Zika virus IgM antibodies in human serum, potassium-EDTA plasma, potassium-EDTA venous whole blood, or fingerstick whole blood specimens.